Asthma in der Schwangerschaft

A. Gillissen; H. Worth

doi:10.1055/s-0028-1085606

DMW - Deutsche Medizinische Wochenschrift, Inhaltsverzeichnis

Dtsch Med Wochenschr 2008; 133(39): 1977-1980
DOI: 10.1055/s-0028-1085606

Aktuelle Diagnostik & Therapie | Review article

Geburtshilfe, Allergologie
© Georg Thieme Verlag KG Stuttgart · New York

Asthma in der Schwangerschaft

Asthma during pregnancyA. Gillissen¹ , H. Worth²

¹Robert-Koch-Klinik, Thoraxzentrum des Klinikums St. Georg, Leipzig
²Med. Klinik I, Klinikum Fürth

Abstract

Schlüsselwörter

Asthma bronchiale - Schwangerschaft - inhalative Glukokortikoide

Key words

asthma - pregnancy - inhaled corticosteroids

Volltext

Referenzen

Literatur

1 Alexander S, Dodds L, Armson B A. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol. 1998; 92 435-440
2 Bachert C, Borchard U, Wedi B. et al . Leitlinie der DGAI zur allergischen Rhinokonjunktivitis. Allergologie. 2003; 26 147-162
3 Blaiss M S. National Institutes of Health . Management of asthma during pregnancy. Allergy Asthma Proc. 2004; 25 375-379
4 Buhl R. et al . Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. Pneumologie. 2006; 60 139-183
5 Carlsen K -H, Carlsen K C. Respiratory effects of tobacco smoking on infants and young children. Paediatr Resp Rev. 2008; 9 11-20
6 Cydulka R K. et al . Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med. 1999; 160 887-892
7 Gillissen A. Die chronisch-obstruktive Lungenerkrankung. Bremen; Uni-Med 2006
8 Gillissen A. Bewertung der Theophyllin-Therapie beim Asthma bronchiale. Münch Med Wschr. 1997; 139 79-72
9 Gluck J C, Gluck P A. The effects of pregnancy on asthma a prospective study. Ann Allergy. 1976; 37 164-168
10 Hylkema M N, Sterk P J, de Boer W I, Postma D S. Tobacco use in relation to COPD and asthma. Eur Respir J. 2007; 29 438-445
11 Jana N. et al . Effect of bronchial asthma on the course of pregnancy, labour and perinatal outcome. J Obstet Gynaecol. 1995; 21 227-232
12 Källén B. The safety of asthma medications during pregnancy. Expert Opin Drug Saf. 2007; 6 15-26
13 Källén B, Otterblad Olausson P O. Use of anti-asthmatic drugs during pregnancy. 1. maternal characteristics, pregnancy and delivery complications. Eur J Clin Pharmacol. 2007; 63 363-373
14 Källén B, Otterblad Olausson P O. Use of anti-asthmatic drugs during pregnancy. 2. infant characteristics excluding congenital malformations. Eur J Clin Pharmacol. 2007; 63 375-381
15 Källén B, Otterblad Olausson P O. Use of anti-asthmatic drugs during pregnancy. 3. congential malformations in the infants. Eur J Clin Pharmacol. 2007; 63 383-388
16 Kleine-Tebbe J, Bergmann K -C, Friedrichs F. et al . Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Allergo J. 2006; 15 56-73
17 Koneczny N, Floer B, Isfort J, Vollmar H C, Butzlaff M. Evidenzbasierte Leitlinie zur Asthma Diagnose und Therapie. Asthma Sonderfälle: Schwangere + Kinder. www.evidence.de. 2004
18 Kuczkowksi K M. Te effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol. 2007; 19 578-585
19 Kwon H L, Belanger K, Bracken M B. Asthma prevalence among pregnant and child bearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol. 2003; 13 317-324
20 Lumley J, Oliver S S, Chamberlain C, Oakley L. Internventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2004 CD001055
21 Mabie W C, Barton J R, Wasserstrum N, Sibai B M. Clinical observations on asthma and pregnancy. J Matern Fetal Med. 1992; 1 45-50
22 Mann R D. Salmeterol: a study by prescription-event monitoring in a UK cohort of 15 407 patients. J Clin Epidemiol. 1996; 49 247-250
23 Murphy V E, Gibson P G, Smith R, Clifton V L. Asthma during pregenancy: mechanisms and treatment implications. Eur Respir J. 2005; 25 731-750
24 National Institutes of Health (Hrsg) .Global strategy for asthma management and prevention NHLBI/WHO Workshop report. Bethesda, USA; U.S. Department of Health and Human Services 2006: 1-176 (www.ginasthma.com)
25 Park-Wyllie L, Mazzotta P, Pastuszak A. et al . Birth defects after maternal exposure to corticosteroids. Teratology. 2000; 62 385-392
26 Salihu H M, Wilson R E. Epidemiology of prenatal smoking and perinatal outcomes. Early Hum Dev. 2007; 83 713-720
27 Schatz M. Interrelationships between asthma and pregnancy: a literature review. J Allergy Clin Immunol. 1999; 103 330-336
28 Schatz M. et al . The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol. 2008; 100 301-306
29 Shanies H M, Venkataraman M T, Peter T. Reversal of intractable acute severe asthma by first-trimester termination of pregnancy. J Asthma. 1997; 34 169-172
30 Suissa S. et al . Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000; 343 332-336
31 U.S.Department of Health and Human Services, National Institutes of Health .National asthma education and prevention program. Working group report on managing asthma during pregnancy: recommendations for pharmacologic treatment. Update 2004/2005. http://www.nhlbi.nih.gov
32 U.S.Food and Drug Administration . U.S. FDA labeling and prescription drug advertising: content and format for labeling for human prescriptions drugs. Fed Regist. 1979; 44 37434-37467
33 Worth H, Butt U, Wettengel R. Empfehlung zur Behandlung von Asthma in der Schwangerschaft. Med Klin. 1996; 91 435-437

Prof. Dr. A. Gillissen

Robert-Koch-Klinik, Thoraxzentrum des Klinikums St. Georg

Nikolai-Rumjanzew-Str. 100

04207 Leipzig

Telefon: 0341/4231-202

Fax: 0341/4231-203

URL: http://www.rkk-leipzig.de